rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Byrna Technologies, Inc.

BYRN · Nasdaq

TechnologyElectronic Components & EMSNot moving yet

BYRN stood above a rising 150-day average in 0 of the last 52 weekly readings. It is 9.3% below that average now. Electronic Components & EMS: 13% of its 96 stocks in an uptrend (−6 points in four weeks); Technology: 29% (−3 points in four weeks).

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 52
Industry in uptrend
13% -6 in 4 wk
Insider buys, 12 months
$966K
Insider sales, 12 months
$0
Officials’ trades on record
1
Institutions holding
105 (-13)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 0 of 52 weeks.

17 Apr – 16 Oct
14%34%55%Apr 26Jun 26Jul 26Sep 26Oct 26

Electronic Components & EMS: Few of its stocks are in an uptrend and the share has been slipping. Technology: A minority of its stocks are in an uptrend and the share has been slipping.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$3.1M$0$621KNov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

1 disclosed lines: House 0, Senate 0, executive 1; 1 people.

WhoDidAmountTraded
Sara Bailey Executive branch: Office of Government EthicsOffice of National Drug Control Policybought$1k–$15k1 Mar 2026filed 11 Jun 2026

Insiders

Buy orders, 12 months16
Sale orders, 12 months0
Buyers · sellers8 · 0
WhoDidSharesTraded
Adam L. RothDirectorbought7,500at $4.7815 Oct 2026filed 16 Oct 2026
Adam L. RothDirectorbought2,500at $4.7515 Oct 2026filed 16 Oct 2026
Adam L. RothDirectorbought5,000at $4.5314 Oct 2026filed 16 Oct 2026
Leonard J. ElmoreDirectorbought10,000at $4.646 Aug 2026filed 10 Aug 2026
Herbert HughesDirectorbought1,499at $3.8628 Jul 2026filed 28 Jul 2026
Herbert HughesDirectorbought2,501at $3.7727 Jul 2026filed 28 Jul 2026
Chris Lavern ReedDirectorbought8,150at $3.6324 Jul 2026filed 28 Jul 2026
Conn Q. DavisChief Executive Officerbought3,340at $3.5123 Jul 2026filed 23 Jul 2026
Herbert HughesDirectorbought3,703at $3.4223 Jul 2026filed 23 Jul 2026
Herbert HughesDirectorbought12,500at $3.4023 Jul 2026filed 23 Jul 2026
Conn Q. DavisChief Executive Officerbought3,430at $3.5123 Jul 2026filed 23 Jul 2026
Laurilee KearnesChief Financial Officerbought2,000at $3.4222 Jul 2026filed 23 Jul 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders105-13 on the quarter
New · exited21 · 34
Reported value$75.2M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
FMR LLCadded · filed 13 Aug 20263,402,809$22.8M+2,268+0.1%
VANGUARD CAPITAL MANAGEMENT LLCreduced · filed 13 Aug 2026758,696$5.1M-7,775−1.0%
Wealthspire Advisors, LLCreduced · filed 11 Aug 2026604,702$4.1M-178,047−22.7%
CITADEL ADVISORS LLCadded · filed 14 Aug 2026529,734$3.6M+496,312+1485.0%
Quinn Opportunity Partners LLCadded · filed 14 Aug 2026478,565$3.2M+254,405+113.5%
RENAISSANCE TECHNOLOGIES LLCadded · filed 13 Aug 2026429,847$2.9M+47,520+12.4%
BlackRock, Inc.reduced · filed 7 Aug 2026404,411$2.7M-967,071−70.5%
PINNACLE ASSOCIATES LTDreduced · filed 3 Aug 2026368,866$2.5M-32,888−8.2%
MONETA GROUP INVESTMENT ADVISORS LLCadded · filed 14 Aug 2026336,638$2.3M+313,163+1334.0%
MILLENNIUM MANAGEMENT LLCreduced · filed 14 Aug 2026325,550$2.2M-749,286−69.7%
31 Mar 2023 – 30 Jun 2026
4081122Mar 23Dec 23Dec 24Sep 25Jun 26

Everyone who traded it

Adam L. Roth Company insiderDirector · last 15 Oct 20262 · 0
Rose P. Keravuori Company insiderDirector · last 12 Aug 20260 · 0
Leonard J. Elmore Company insiderDirector · last 6 Aug 20261 · 0
Chris Lavern Reed Company insiderDirector · last 29 Jul 20262 · 0
Emily Rooney Company insiderDirector · last 29 Jul 20261 · 0
Herbert Hughes Company insiderDirector · last 29 Jul 20264 · 7
Tj Kennedy Company insiderDirector, Other · last 29 Jul 20261 · 0
Conn Q. Davis Company insiderChief Executive Officer · last 23 Jul 20264 · 0
Laurilee Kearnes Company insiderChief Financial Officer · last 22 Jul 20263 · 0
Bryan Ganz Company insiderOther · last 15 Apr 202610 · 10
Luan Pham Company insiderOther · last 17 Mar 20264 · 1
Sara Bailey Executive branchOffice of National Drug Control Policy · last 1 Mar 20261 · 0

Same industry

ATKR AtkoreLeading+18%
PI ImpinjIn trend+20%
APH AmphenolIn trend+4%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Profit per saleFY 2025 · to 30 Nov 202560.5%
Operating profit marginFY 2025 · to 30 Nov 202510.0%
Free cash flow marginFY 2025 · to 30 Nov 2025-7.8%
Return on capital employedFY 2025 · to 30 Nov 202517.6%
Cash conversionFY 2025 · to 30 Nov 2025-16.2%
Research spendFY 2025 · to 30 Nov 20250.3%
Share count trendFY 2025 · to 5 Feb 2026-0.0%
Cash and equivalentsFY 2025 · to 30 Nov 2025$13.7M
Free cash flowFY 2025 · to 30 Nov 2025−$9.2M

Analyst forecasts

No analyst forecasts yet.